Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Metastable States of ^{92,94}Se: Identification of an Oblate K Isomer of ^{94}Se and the Ground-State Shape Transition between N=58 and 60.

Physical review letters·2020

Same author

<sup>78</sup>Ni revealed as a doubly magic stronghold against nuclear deformation.

Nature·2019

Same author

Pseudospin Symmetry and Microscopic Origin of Shape Coexistence in the ^{78}Ni Region: A Hint from Lifetime Measurements.

Physical review letters·2018

Same author

Erratum: Persistence of the Z=28 Shell Gap Around ^{78}Ni: First Spectroscopy of ^{79}Cu [Phys. Rev. Lett. 119, 192501 (2017)].

Physical review letters·2018

Same author

Safety assessment in Child A cirrhotic patients treated with Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin.

Acta gastro-enterologica Belgica·2018

Same author

Persistence of the Z=28 Shell Gap Around ^{78}Ni: First Spectroscopy of ^{79}Cu.

Physical review letters·2017

Search research articles

Related Experiment Video

Updated: May 25, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Postradiotherapy regression--a prognostic factor in rectal neoplasm.

M Marincas¹, C Cirimbei, V Prunoiu

¹The Clinic of Surgery I, The Oncological Institute of Bucharest, Romania. marincasro@yahoo.com

Chirurgia (Bucharest, Romania : 1990)

|February 8, 2012

Summary

This summary is machine-generated.

Radiotherapy response in rectal cancer varies greatly, impacting patient prognosis. This study proposes a clinical trial to identify markers predicting treatment response and long-term outcomes for personalized rectal cancer care.

More Related Videos

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine

Published on: October 13, 2023

Related Experiment Videos

Last Updated: May 25, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine

Published on: October 13, 2023

Area of Science:

Oncology
Radiation Oncology
Pathology

Background:

Preoperative radiotherapy is a standard treatment for rectal cancer, aiming to reduce tumor volume and lymph node involvement.
Observed responses to preoperative radiotherapy in rectal cancer patients are highly variable, ranging from complete tumor disappearance to no response.
Current methods for predicting treatment response and patient prognosis are limited.

Purpose of the Study:

To propose a clinical trial investigating tumor grading, immunohistochemical markers, and genetic changes to assess rectal cancer response to preoperative radiotherapy.
To establish criteria for stratifying patients into regression groups based on pre-therapeutic characteristics.
To potentially personalize preoperative radiation strategies based on predicted treatment response and prognosis.

Main Methods:

The study proposes a clinical trial design.
It will examine tumor grading, immunohistochemical markers, and genetic alterations.
Analysis will focus on assessing the degree of post-radiotherapy tumor regression and predicting long-term prognosis.

Main Results:

Preliminary statistical data supports the study's working hypothesis.
The variability in radiotherapy response necessitates better predictive tools.
Identifying predictive markers could refine treatment strategies.

Conclusions:

Tumor grading, immunohistochemical markers, and genetic factors may predict rectal cancer response to preoperative radiotherapy.
Stratifying patients based on these criteria could lead to more effective, personalized treatment plans.
This approach may help optimize or even modify standard preoperative radiation protocols for improved patient outcomes.